Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance ...Middle East

In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome ZUG, Switzerland, April 14, 2022 /PRNewswire/ -- Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of...

Hence then, the article about micreos pharmaceuticals announces success of its xz 700 technology in selectively eliminating staphylococcus aureus pathogen without triggering resistance was published today ( Thursday 14/04/2022 - 10:42 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance )

Also on site :

• Storyteq wurde im 2026 Gartner® Magic Quadrant™ for Content Marketing Platforms als Leader ausgezeichnet
• Tehran Takes the Strait — and the Premium
• CoVet behaalt ISO 27001-certificering ter ondersteuning van veilige AI-workflows in de diergeneeskunde